Epidemiologic and Ecologic Features of Blastomycosis: A Review
- 298 Downloads
Blastomycosis is a potentially fatal infection caused by Blastomyces dermatitidis, a fungus endemic to North America in areas surrounding the Ohio and Mississippi River valleys and the Great Lakes. The clinical manifestations, diagnostic techniques, and treatment strategies for blastomycosis are relatively well-described in the literature; however, the epidemiologic features of disease are not as clearly defined as those of other endemic mycoses, such as histoplasmosis and coccidioidomycosis. We review the ecologic and epidemiologic aspects of B. dermatitidis and blastomycosis, including geographic distribution, environmental niche, seasonality, and possible risk factors.
KeywordsBlastomycosis Blastomyces Fungus Epidemiology Ecology Risk factor Prevention
The findings and conclusions of this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
K. Benedict: none; M. Roy: none; T. Chiller: none; J. P. Davis: none.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 8.Stovall SH, Schutze GE. Blastomycosis. In: Feigin RD, Cherry JD, Demmler-Harrison GJ, Kaplan SL, editors. Feigin & Cherry’s textbook of pediatric infectious diseases. 6th ed. Philadelphia: Saunders Elsevier; 2009. p. 2732–40.Google Scholar
- 15.• Babady NE, Buckwalter SP, Hall L, Le Febre KM, Binnicker MJ, Wengenack NL. Detection of Blastomyces dermatitidis and Histoplasma capsulatum from culture isolates and clinical specimens by use of real-time PCR. J Clin Microbiol. 2011;49(9):3204–8. This paper describes the use of a newly developed real-time PCR assay for the detection of B. dermatitidis and H. capsulatum. The results indicate that the assay is a sensitive and specific method for detecting and differentiating these two fungi from culture isolates and directly from certain types of clinical specimens. PubMedCrossRefGoogle Scholar
- 21.National Institute of Allergy and Infectious Diseases Mycoses Study Group. Treatment of blastomycosis and histoplasmosis with ketoconazole. Results of a prospective randomized clinical trial. Ann Intern Med. 1985;103(6 Pt 1):861–72.Google Scholar
- 39.• Pfister JR, Archer JR, Hersil S, et al. Non-rural point source blastomycosis outbreak near a yard waste collection site. Clin Med Res. 2011;9(2):57–65. This paper describes the blastomycosis outbreak that occurred in Lincoln County, Wisconsin during 2006. A large yard waste site was identified as the probable source of exposure, and B. dermatitidis nucleic acid was detected in an environmental sample from this site. PubMedCrossRefGoogle Scholar
- 40.Blastomycosis in Wisconsin, 1985–1994. Wis Epidemiol Bull. 1995;16(2):1–5.Google Scholar
- 49.Denton JF, Disalvo AF. Isolation of Blastomyces dermatitidis from natural sites at Augusta, Georgia. AmJTrop Med Hyg. 1964;13:716–22.Google Scholar
- 50.Denton JF, DiSalvo AF. Additional isolations of Blastomyces dermatitidis from natural sites. AmJTrop Med Hyg. 1979;28(4):697–700.Google Scholar
- 69.Choptiany M, Wiebe L, Limerick B, et al. Risk factors for acquisition of endemic blastomycosis. Can J Infect Dis. 2009;20(4):117–21.Google Scholar
- 73.Roy M, Deak E, Benedict K, et al. The lung fungus among us: a large urban outbreak of blastomycosis–Marathon County, Wisconsin, 2010 (oral presentation). In: Abstracts of the 60th Annual Epidemic Intelligence Service Conference. Atlanta, GA, April 11–15, 2011, p. 54.qqGoogle Scholar
- 75.Brown S. The fungus among us: blasto isolated in the home environment. In: National Environmental Health Association 76th Annual Education Conference & Exhibition. San Diego, CA, 2012.Google Scholar
- 77.• Grim SA, Proia L, Miller R, et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis. 2012;14(1):17–23. Results of a multicenter retrospective review of solid organ transplant recipients demonstrated that although the incidence of posttransplant blastomycosis in the overall study cohort was low (<1 %), the infection was associated with a high mortality rate. PubMedCrossRefGoogle Scholar
- 83.• Wuthrich M, Krajaejun T, Shearn-Bochsler V, et al. Safety, tolerability, and immunogenicity of a recombinant, genetically engineered, live-attenuated vaccine against canine blastomycosis. Clin Vaccine Immunol. 2011;18(5):783–9. This study demonstrated that a live attenuated vaccine against blastomycosis in dogs is safe, well-tolerated, and immunogenic. These findings underscore the importance of future research on a potential human vaccine against blastomycosis. PubMedCrossRefGoogle Scholar